MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Radiology

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00330-016-4685-8PMID 28004161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging

  2016cited by this paper
• Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

  2016cited by this paper
• Association between 18F-FDG uptake and molecular subtype of breast cancer

  2015cited by this paper
• Breast MRI used as a problem-solving tool reliably excludes malignancy.

  2015cited by this paper
• Prone 18F-FDG PET/CT changes diagnostic and surgical intervention in a breast cancer patient: some considerations about PET/CT imaging acquisition protocol.

  2015cited by this paper
• Development of an online, publicly accessible naive Bayesian decision support tool for mammographic mass lesions based on the American College of Radiology (ACR) BI-RADS lexicon

  2015cited by this paper
• Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?

  2014cited by this paper
• Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.

  2014cited by this paper
• Improved Differentiation of Benign and Malignant Breast Tumors with Multiparametric 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging: A Feasibility Study

  2014cited by this paper
• Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis.

  2014cited by this paper
• [Contribution of time of flight and point spread function modeling to the performance characteristics of the PET/CT Biograph mCT scanner].

  2013cited by this paper
• Impact of Time-of-Flight and Point-Spread-Function in SUV Quantification for Oncological PET

  2013cited by this paper
• Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer.

  2013cited by this paper
• Contribution of time of flight and point spread function modeling to the performance characteristics of the PET/CT Biograph mCT scanner ☆

  2013cited by this paper
• Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.

  2011cited by this paper
• Role of Fusion of Prone FDG‐PET and Magnetic Resonance Imaging of the Breasts in the Evaluation of Breast Cancer

  2010cited by this paper
• Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging

  2010cited by this paper
• 18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization*

  2009cited by this paper
• Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

  2008cited by this paper
• Meta-analysis of MR imaging in the diagnosis of breast lesions.

  2008cited by this paper
• Improving Specificity of Breast MRI Using Prone PET and Fused MRI and PET 3D Volume Datasets

  2007cited by this paper
• FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions

  2004cited by this paper
• Follow-up of women with breast cancer: comparison between MRI and FDG PET

  2003cited by this paper

• Une imagerie innovante, la TEP-IRM : à propos du cancer du sein et du col utérin

  2024cites this paper
• Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging

  2023cites this paper
• Assessment and Response to Neoadjuvant Treatments in Breast Cancer: Current Practice, Response Monitoring, Future Approaches and Perspectives.

  2023cites this paper
• The expression of Ki-67 and Glypican -3 in hepatocellular carcinoma was evaluated by comparing DWI and 18F-FDG PET/CT

  2023cites this paper
• DIAGNOSTIC ACCURACY OF ARTIFICIAL INTELLIGENCE FOR ANALYSIS OF 1.3 MILLION MEDICAL IMAGING STUDIES: THE MOSCOW EXPERIMENT ON COMPUTER VISION TECHNOLOGIES

  2023cites this paper
• A Role of PET/MR in Breast Cancer?

  2022cites this paper
• Clinical advances in PET-MRI for breast cancer.

  2022cites this paper
• Diagnostic Performance of PET/MRI in Breast Cancer: A Systematic Review and Bayesian Bivariate Meta-analysis.

  2022cites this paper
• Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer

  2020cites this paper
• Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI

  2018cites this paper
• PET/MRI and Molecular Imaging in Breast Cancer

  2018cites this paper
• PET/MRI in Breast Cancer

  2018cites this paper
• PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

  2018cites this paper
• PET/MR Imaging: Current and Emerging Applications

  2018cites this paper